Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-19-004046
Filing Date
2019-06-07
Accepted
2019-06-07 17:11:08
Documents
1
Period of Report
2019-05-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 8719
  Complete submission text file 0000919574-19-004046.txt   11430
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Reporting) CIK: 0001601086 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 033-80623 | Film No.: 19886802

Mailing Address C/O ARMISTICE CAPITAL, LLC 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address C/O ARMISTICE CAPITAL, LLC 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 212-231-4932
Armistice Capital Master Fund Ltd. (Reporting) CIK: 0001633584 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 033-80623 | Film No.: 19886803

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address
Boyd Steven (Reporting) CIK: 0001706140 (see all company filings)

Type: 3 | Act: 34 | File No.: 033-80623 | Film No.: 19886804